RE: Should be 50% up26 Apr 2024 09:59
Re-reading the recent RNS, Sale of Accredited in Q2 - so anytime from now until June
They say that the Legacy Plan outlined in the December Circular RNS remains achievable (although may take longer to fully implement)
and this from the Circular:
The non-life legacy market is significant and growing, with total global reserves estimated at $960 billion in 2022, an increase of $96 billion from the previous year1. R&Q has a strong pipeline, with identified transactions comprising over $850 million of reserves, including three deals in advanced stages with in aggregate over $100 million of reserves. Going forward, R&Q will continue to focus on transactions in the small to medium size range, where competition is less intense, and to offer compelling finality solutions for corporates in the US, UK and Europe. This follows R&Q's landmark deal earlier in 2023 to invest alongside Obra Capital, Inc. to acquire and professionally manage the non-insurance legacy liabilities of MSA Safety Inc. This strategy, alongside Gibson Re, will generate fees from two distinct but complementary pools of liabilities: traditional insurance reserves and corporate non-insurance liabilities.